C3.Ai, Inc. SEC Filings

C3.ai Executive Chairman Thomas M. Siebel reported option exercises and share sales of Class A common stock. On January 13, 2026, he exercised a stock option for 212,586 shares at an exercise price of $2.04 per share and acquired the same number of Class A shares.

That day, he sold 212,586 Class A shares directly at a weighted-average price of $13.52 per share and a further 309,589 shares indirectly through an entity associated with him, in multiple trades between $13.265 and $14.20. The activity was carried out under a previously established Rule 10b5-1 trading plan dated September 20, 2024. Following these transactions, he continued to hold both direct and indirect positions in C3.ai stock, including option holdings that remain outstanding and fully vested.

C3.ai, Inc. Chief Executive Officer Stephen Bradley Ehikian reported several equity transactions in the company’s Class A common stock. On 12/30/2025, he received a grant of 18,090 Restricted Stock Units (RSUs), each representing one share of Class A common stock, which the filing states are fully vested. On 12/31/2025, 234,918 shares of Class A common stock were automatically withheld and sold by the company to cover his tax withholding obligations related to vested RSUs, at a weighted-average price of $13.56 per share.

Following these transactions, the filing shows changes in how his holdings are structured. On 01/02/2026, 182,488 shares moved from his direct ownership at no stated price, and the same number of shares were then listed as indirectly owned through the Stephen Bradley Ehikian Revocable Trust, for which he is the sole trustee. After the reported transactions, he beneficially owned 924,074 shares directly and 182,488 shares indirectly through the trust.

AI received a notice that a holder plans to sell restricted shares under Rule 144. The planned sale covers 234,918 common shares through Merrill Lynch on the NYSE, with an indicated aggregate market value of $3,184,990.76. The issuer reports 137,253,289 shares of this class outstanding. The securities to be sold were acquired on 12/30/2025 through the vesting of 417,406 restricted stock units, with the same date shown for payment. The seller confirms they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

C3.ai, Inc. Executive Chairman, director and 10% owner Thomas M. Siebel reported selling Class A common stock in mid-December 2025. On December 16, 2025, he sold 392,064 shares at a weighted-average price of $14.37, and on December 17, 2025, he sold 140,768 shares at a weighted-average price of $14.22. The filing states these transactions were made under a pre-established Rule 10b5-1 trading plan dated September 20, 2024.

Following these transactions, Siebel continues to beneficially own significant amounts of C3.ai stock, including indirect holdings through The Siebel Living Trust and several affiliated entities such as First Virtual Holdings, Siebel Asset Management partnerships, and The Siebel 2011 Irrevocable Children's Trust.

C3.ai, Inc. reported an insider equity transaction by one of its directors. On December 15, 2025, the director disposed of 2,500 shares of Class A common stock at $14.65 per share in a transaction linked to restricted stock units. A footnote explains that 2,500 of 5,000 restricted stock units that vested on that date were settled in cash rather than in shares.

Following this transaction, the director beneficially owned 130,658 Class A shares directly and 102,886 Class A shares indirectly through The Hyten Group LLC, where the reporting person is the manager and sole member.

C3.ai’s Chief Financial Officer reported equity compensation activity involving the company’s Class A common stock. On December 15, 2025, restricted stock units (RSUs) converted into 8,008, 1,000 and 20,000 shares at an exercise price of $0, increasing the officer’s direct holdings.

On December 16, 2025, 15,042 shares were automatically sold at a weighted-average price of $14.38 to satisfy tax withholding obligations related to the RSU vesting. After these transactions, the officer directly owned 223,120 Class A shares and continued to hold RSUs that vest over time as service with the company continues.

C3.ai, Inc. reported that a company director received a grant of stock options covering 34,091 shares of Class A common stock at an exercise price of $15.92 per share.

The options were granted on December 11, 2025 and are scheduled to vest in 12.5% installments at the end of each fiscal quarter from the vesting commencement date until the second anniversary, if the director remains on the board and attends the regularly scheduled board meetings in person during each quarter.

Any quarterly portion that does not vest because the director misses a regularly scheduled meeting is suspended and can vest only after the second anniversary if later attendance requirements are met, and the options expire on December 10, 2035.

C3.ai, Inc. executive chairman, director and 10% owner Thomas M. Siebel reported multiple equity transactions in December 2025. On 12/11/2025, 44,767 restricted stock units vested into Class A common stock and he received a new grant of 722,362 RSUs, which vest 33% on December 11, 2026 and then quarterly. On 12/12/2025, 23,000 shares were sold at a weighted-average price of $15.94 to cover tax withholding obligations linked to the RSU vesting.

On the same date, he also received a stock option to buy 1,133,474 Class A shares at an exercise price of $17.512 per share, vesting in three equal annual installments starting December 11, 2026 and expiring on December 10, 2035. Following these transactions, he reports 722,362 shares held directly and additional indirect holdings through family trusts and investment entities.

C3.ai, Inc. reported weaker results for the quarter ended October 31, 2025. Total revenue fell to $75.1 million from $94.3 million a year earlier, driven by lower subscription revenue and a sharp drop in professional services. For the first six months, revenue declined to $145.4 million from $181.6 million.

Operating costs continued to rise, especially in sales and marketing, research and development, and general and administrative expenses. As a result, the quarterly net loss widened to $104.7 million from $66.0 million, and the six‑month net loss increased to $221.4 million from $128.8 million. Stock-based compensation was significant at $68.9 million for the quarter and $133.6 million year-to-date.

Cash, cash equivalents and marketable securities remained sizable, with marketable securities of $571.8 million and cash and cash equivalents of $103.2 million as of October 31, 2025. However, the company used $80.0 million of cash in operating activities over six months. Remaining performance obligations totaled $232.5 million, with $136.0 million expected to be recognized as revenue over the next 12 months.